Skip to content
IFPMA Twitter
IFPMA LinkedIn
IFPMA Youtube
IFPMA Slideshare
IFPMA Flickr
IFPMA RSS
Search for:
Primary Menu
Who We Are
IFPMA in Brief
Our Governance and Leadership
Our Membership
Full Members
Associations
Companies
Affiliate Members
Our Experts
Join Us
Topics
News Center
News Releases
Blog
Global Health Matters
Science Matters
DG’s Column
Statements
Resources
Publications
News Releases
Statements
Position Papers
Publications
External Studies
Infographics
Event Highlights
Multimedia
Interviews
Videos
Slides
IFPMA Interactive Platforms
IFPMA COVID-19 Hub
Global Health Progress
50 Years of Global Health Progress
Events
Upcoming IFPMA Events
Geneva Pharma Forums
Assemblies
Other IFPMA Events
IFPMA in External Events
IFPMA Press Briefings
Past IFPMA Events
Geneva Pharma Forums
Assemblies
Other IFPMA Events
IFPMA in External Events
IFPMA Press Briefings
Partners
BCR
Inventing Medicines and Vaccines
Strengthening Regulatory Systems
Ethics and Business Integrity
Boosting Innovation and Access
Tackling Global health challenges
Climate change
Economic footprint
IP
Sustainable innovation
Value of innovation
spotlight
Value of innovation
African Medicines Agency
Biosimilars
Biotherapeutic medicines
Falsified medicines
Import testing
Pharmacovigilance
Quality, safety, and efficacy
Regulatory conferences
Regulatory system strengthening / Harmonization
Supply chain
The Africa Regulatory Network (ARN)
The ARN: Le réseau africain de réglementation pharmaceutique
spotlight
Pharmacovigilance
IFPMA Code of Practice (2019)
Our Ethos in Action
Our Ethos
Code eLearning Tool
IFPMA Notes for Guidance
IFPMA Complaint Operating Procedure
How to File a Code Complaint
Complaint Submission Form
Cases
Business Ethics for APEC SMEs Initiative
Consensus Framework for Ethical Collaboration
spotlight
IFPMA Code of Practice (2019)
Access to medicines
Global Policy Principles on Digital Health
Health technology assessment
IP
Technology Transfer
Trade
spotlight
Access to medicines
Ageing
Antimicrobial resistance
Cancer
Child and maternal health
COVID-19
Diabetes
Ebola
Falsified medicines
HIV/AIDS
Influenza
Malaria
Mental and neurological disorders
Neglected tropical diseases
Non-communicable diseases
Pandemic Preparedness
Public health implications of the implementation of the Nagoya Protocol
Rare diseases
Supply chain
Sustainable development goals
Tuberculosis
Universal Health Coverage
Vaccination confidence
Vaccines innovation
Vaccines protect communities
Vaccines sustainability
Value of immunization
Viral hepatitis
spotlight
Universal Health Coverage
Home
>
Tag: Non-Communicable Diseases
Tag: Non-Communicable Diseases
World cancer day: R&D pharmaceutical industry partnerships to enhance access to cancer care
Diabetes
HealthyScore
Assessing the value of treatment for diabetes to patients, the healthcare system, and wider society - A case study on China
Framework for action for the prevention and control of non-communicable diseases
Cancer
Ageing
Sustainable development goals
Population attitude to personal health in Thailand
Partnering to learn more about prevention of non-communicable diseases
Psoriasis
'4 Healthy Habits': mobilizing volunteers to help fight noncommunicable diseases
Bringing psoriasis into the light
Partnership in Fighting Non-Communicable Diseases
The Joint IFRC-IFPMA Reception on the occasion of the 67th World Health Assembly
Bringing psoriasis into light
Addressing the gaps in global policy and research for non-communicable diseases
R&D-based pharmaceutical industry and International Federation of Red Cross and Red Crescent Societies join forces to prevent NCDs
Introduction - Mario Ottiglio, director, public affairs and global health policy, IFPMA
Community-Based Prevention of Non-Communicable Diseases: Successes and Challenges
Global pharmaceutical industry contributes action plan and research to fighting NCDs in the developing world
WHA 64, Item 13.12, Prevention and control of non-communicable diseases
Russians evidently overestimate their state of health as good and fair
Improving access to medicines for non-communicable diseases in the developing world
WHPA health improvement card
A shared commitment to fight non-communicable disease
Other Tags
Access
Access to antiretrovirals
Access to Medicines
Access to vaccines
Africa
AMR
AMR Industry Alliance
Anti-Counterfeit
Antibiotics
antimicrobial resistance
antivirals
Biosimilars
Biotherapeutic Medicines
Biotherapeutics
Cancer
Clinical Trials
Code of Practice
collaboration
Counterfeit Medicines
Counterfeits
COVID-19
COVID-19 vaccines
Dementia
Developing World
Diabetes
Economic footprint
Epidemics
Ethics
Event Highlights
Fake Medicines
Fakes
Falsified Medicines
Fight the Fakes
Flu
Global Health
global health security
harmonization
Health
Health Partnerships
HIV/AIDS
IFPMA
IFPMA Assembly
IFPMA Statement
Immunization
Incremental Innovation
Influenza
Infographic
Infographics
Innovation
Innovation ecosystem
Intellectual Property
IP
Malaria
MDGs
Medicines
Mental and Neurological Disorders
NCDs
Neglected Tropical Diseases
News Releases
Non-Communicable Diseases
Novel Coronavirus (COVID-19)
NTDs
pandemic
Pandemic Influenza
Pandemic preparedness
pandemics
partnership
Partnerships
Pharma
Pharmacovigilance
Position Paper
Prevention
Publications
Public Health
Quality
R&D
Regulatory
regulatory systems
Related Links
Research
Safety
SDGs
Seasonal Influenza
Statements
Supply chain
Sustainable Development Goals
Sustainable Innovation
trade
Treatments
Tuberculosis
UHC
Universal Health Coverage
Vaccine
Vaccines
Value of Innovation
Videos
WHA
WHO
WIPO
Women’s Cancers